Angiopoietin 1 and 2 Levels in Inhaled Steroid Using Children with Stable Asthma

dc.contributor.authorKoksal, Burcu
dc.contributor.authorOzbek, Ozlem Yilmaz
dc.contributor.orcID0000-0001-9580-7656en_US
dc.contributor.orcID0000-0003-2974-9579en_US
dc.contributor.pubmedID27742088en_US
dc.contributor.researcherIDAAF-2109-2021en_US
dc.contributor.researcherIDAAJ-2034-2021en_US
dc.contributor.researcherIDHKW-0623-2023en_US
dc.date.accessioned2023-06-26T11:40:00Z
dc.date.available2023-06-26T11:40:00Z
dc.date.issued2016
dc.identifier.eissn1534-4436en_US
dc.identifier.endpage448en_US
dc.identifier.issn1081-1206en_US
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-84992184526en_US
dc.identifier.startpage448en_US
dc.identifier.urihttp://hdl.handle.net/11727/9847
dc.identifier.volume117en_US
dc.identifier.wos000386496400030en_US
dc.language.isoengen_US
dc.relation.isversionof10.1016/j.anai.2016.07.031en_US
dc.relation.journalANNALS OF ALLERGY ASTHMA & IMMUNOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleAngiopoietin 1 and 2 Levels in Inhaled Steroid Using Children with Stable Asthmaen_US
dc.typeletteren_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: